Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;8(6):793-802.
doi: 10.1586/erc.10.27.

Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics

Julio D Duarte  1 , Rhonda M Cooper-DeHoff
Affiliations
Review

Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics

Julio D Duarte et al. Expert Rev Cardiovasc Ther. 2010 Jun.

Abstract

Thiazide and thiazide-like diuretics are among the most commonly used antihypertensives and have been available for over 50 years. However, the mechanism by which these drugs chronically lower blood pressure is poorly understood. Possible mechanisms include direct endothelial- or vascular smooth muscle-mediated vasodilation and indirect compensation to acute decreases in cardiac output. In addition, thiazides are associated with adverse metabolic effects, particularly hyperglycemia, and the mechanistic underpinnings of these effects are also poorly understood. Thiazide-induced hypokalemia, as well as other theories to explain these metabolic disturbances, including increased visceral adiposity, hyperuricemia, decreased glucose metabolism and pancreatic beta-cell hyperpolarization, may play a role. Understanding genetic variants with differential responses to thiazides could reveal new mechanistic candidates for future research to provide a more complete understanding of the blood pressure and metabolic response to thiazide diuretics.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Theoretical mechanisms of thiazide-induced chronic blood pressure lowering
eNOS: Endothelial nitric oxide synthase; KCA: Calcium-activated potassium; TPR: Total peripheral resistance.
Figure 2
Figure 2
Theoretical mechanisms of thiazide-induced glycemic effects.
See this image and copyright information in PMC

References

    1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):480–486. - PubMed
    1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252. - PubMed
    1. Ellison DH, Velazquez H, Wright FS. Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol. 1987;253(3 Pt 2):F546–F554. - PubMed
    1. Bachmann S, Velazquez H, Obermuller N, Reilly RF, Moser D, Ellison DH. Expression of the thiazide-sensitive Na–Cl cotransporter by rabbit distal convoluted tubule cells. J Clin Invest. 1995;96(5):2510–2514. - PMC - PubMed
    1. Obermuller N, Bernstein P, Velazquez H, et al. Expression of the thiazide-sensitive Na–Cl cotransporter in rat and human kidney. Am J Physiol. 1995;269(6 Pt 2):F900–F910. - PubMed

Website

    1. Drug Topics. www.modernmedicine.com/modernmedicine/data/articlestandard/drugtopics/19....

Publication types

MeSH terms